UK markets closed

Avem Health Partners, Inc. (FPCG)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1,025.000.00 (0.00%)
At close: 11:11AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 256.63k
Enterprise value 4.19M
Trailing P/E 0.09
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.04
Price/book (mrq)0.05
Enterprise value/revenue 0.18
Enterprise value/EBITDA 0.43

Trading information

Stock price history

Beta (5Y monthly) -9.48
52-week change 30.00%
S&P500 52-week change 322.38%
52-week high 31,025.00
52-week low 31,025.00
50-day moving average 31,025.00
200-day moving average 31,025.00

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 59.83k
Implied shares outstanding 69.83k
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short (10 Jan 2002) 4N/A
Short ratio (10 Jan 2002) 43.87
Short % of float (10 Jan 2002) 4N/A
Short % of shares outstanding (10 Jan 2002) 40.00%
Shares short (prior month 12 Nov 2001) 43

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Apr 2021
Ex-dividend date 418 May 2022
Last split factor 21:2000
Last split date 327 Oct 2014

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2013
Most-recent quarter (mrq)30 Jun 2014

Profitability

Profit margin 38.84%
Operating margin (ttm)38.96%

Management effectiveness

Return on assets (ttm)15.63%
Return on equity (ttm)68.90%

Income statement

Revenue (ttm)23.11M
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)32.10%
Gross profit (ttm)N/A
EBITDA 9.7M
Net income avi to common (ttm)8.78M
Diluted EPS (ttm)10,992.00
Quarterly earnings growth (yoy)56.00%

Balance sheet

Total cash (mrq)1.89M
Total cash per share (mrq)158.09
Total debt (mrq)5.82M
Total debt/equity (mrq)33.50%
Current ratio (mrq)5.06
Book value per share (mrq)415.98

Cash flow statement

Operating cash flow (ttm)3.51M
Levered free cash flow (ttm)113.62k